CoChat

Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice

Open access
Zhang, Hong, Zheng, Lu, Li, Chuwei, Jing, Jun, Li, Zhou, Sun, Shanshan, Xue, Tongmin, Zhang, Kemei, Xue, Mengqi, Cao, Chun, Ouyang, Lei, Qian, Zhang, Xu, Rui, He, Zhaowanyue, Ma, Rujun, Chen, Li, Yao, Bing · 2023 · Journal of Ovarian Research

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Background: Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder that frequently exhibits low-grade inflammation, pro-oxidant activity, and gut dysbiosis. PCOS has become one of the leading causes of female infertility worldwide. Recently, omega-3 polyunsaturated fatty acids (PUFAs) have been proven to benefit metabolic disorders in PCOS patients. However, its roles in the regulation of metabolic and endocrinal balances in PCOS pathophysiology are not clear. In the present study, we aimed to explore how omega-3 PUFAs alleviate ovarian dysfunction and insulin resistance in mice with dehydroepiandrosterone (DHEA)-induced PCOS by modulating the gut microbiota. Methods: We induced PCOS in female mice by injecting them with DHEA and then treated them with omega-3 PUFAs. 16S ribosomal DNA (rDNA) amplicon sequencing, fecal microbiota transplantation (FMT) and antibiotic treatment were used to evaluate the role of microbiota in the regulation of ovarian functions and insulin resistance (IR) by omega-3 PUFAs. To further investigate the mechanism of gut microbiota on omega-3-mediated ovarian and metabolic protective effects, inflammatory and oxidative stress markers in ovaries and thermogenic markers in subcutaneous and brown adipose tissues were investigated. Results: We found that oral supplementation with omega-3 PUFAs ameliorates the PCOS phenotype. 16S rDNA analysis revealed that omega-3 PUFA treatment increased the abundance of beneficial bacteria in the gut, thereby alleviating DHEA-induced gut dysbiosis. Antibiotic treatment and FMT experiments further demonstrated that the mechanisms underlying omega-3 benefits likely involve direct effects on the ovary to inhibit inflammatory cytokines such as IL-1β, TNF-α and IL-18. In addition, the gut microbiota played a key role in the improvement of adipose tissue morphology and function by decreasing multilocular cells and thermogenic markers such as Ucp1, Pgc1a, Cited and Cox8b within the subcutaneous adipose tissues. Conclusion: These findings indicate that omega-3 PUFAs ameliorate androgen-induced gut microbiota dysbiosis. The gut microbiota plays a key role in the regulation of omega-3-mediated IR protective effects in polycystic ovary syndrome mice. Moreover, omega-3 PUFA-regulated improvements in the ovarian dysfunction associated with PCOS likely involve direct effects on the ovary to inhibit inflammation. Our findings suggest that omega-3 supplementation may be a promising therapeutic approach for the treatment of PCOS by modulating gut microbiota and alleviating ovarian dysfunction and insulin resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13048-023-01227-w

Cites

Statistics

Figures

Fig. 1 Omega-3 PUFA supplementation attenuates metabolic and endocrine disorders in DHEA-induced PCOS mice. A Experimental design. B Body weights (n = 6). C-G The serum levels of FSH (C), LH (D), E2 (E), T (F) and LH/FSH (G) were measured by ELISA (n = 6). H Fasting blood glucose (n = 10). I GTT (n = 10). J ITT (n = 10), * represents the control group compared to the PCOS group, and # represents PCOS mice compared to the omega-3 group. The data are shown as the mean ± SEM with individual values. Statistical analyses were carried out using one-way ANOVA followed by Dunnett’s multiple comparisons test (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001). FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol 2; T, testosterone; GTT, glucose tolerance test; ITT, insulin tolerance test
Fig. 1 Omega-3 PUFA supplementation attenuates metabolic and endocrine disorders in DHEA-induced PCOS mice. A Experimental design. B Body weights (n = 6). C-G The serum levels of FSH (C), LH (D), E2 (E), T (F) and LH/FSH (G) were measured by ELISA (n = 6). H Fasting blood glucose (n = 10). I GTT (n = 10). J ITT (n = 10), * represents the control group compared to the PCOS group, and # represents PCOS mice compared to the omega-3 group. The data are shown as the mean ± SEM with individual values. Statistical analyses were carried out using one-way ANOVA followed by Dunnett’s multiple comparisons test (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001). FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol 2; T, testosterone; GTT, glucose tolerance test; ITT, insulin tolerance testCC BY · PubMed Central
Fig. 2 Omega-3 PUFAs attenuate ovarian dysfunction in DHEA-induced PCOS mice. A Representative images of ovarian sections. Scale bars: 100 μm. The asterisk (*) represents the corpus luteum, and the pound sign (#) represents the ovary vacuoles. B Estrous cycle changes. C Ovarian index. D-G Representative estrous cycles in representative mice from diverse groups. The data are shown as the mean ± SEM with individual values. Statistical analyses were carried out using one-way ANOVA followed by Dunnett’s multiple comparisons test (**P < 0.01; ***P < 0.001). P, proestrus stage; E, estrus stage; M, metestrus stage; D, diestrus stage.
Fig. 2 Omega-3 PUFAs attenuate ovarian dysfunction in DHEA-induced PCOS mice. A Representative images of ovarian sections. Scale bars: 100 μm. The asterisk (*) represents the corpus luteum, and the pound sign (#) represents the ovary vacuoles. B Estrous cycle changes. C Ovarian index. D-G Representative estrous cycles in representative mice from diverse groups. The data are shown as the mean ± SEM with individual values. Statistical analyses were carried out using one-way ANOVA followed by Dunnett’s multiple comparisons test (**P < 0.01; ***P < 0.001). P, proestrus stage; E, estrus stage; M, metestrus stage; D, diestrus stage.CC BY · PubMed Central
Fig. 3 Omega-3 PUFA treatment has an obvious effect on the α-diversity but not β-diversity of the gut microbiota in PCOS mice. The microbiota composition of control, PCOS and omega-3 mice was analyzed by 16 S rDNA pyrosequencing (n = 3 for each group). A Shannon curve. B Sob index. C Chao1 index. D Ace index. E UPGMA clustering method. F PCA of gut microbiota based on the OTU data of the control, PCOS, and omega-3 groups. PCA, principal component analysis; UPGMA, unweighted pair group method using arithmetic average. The data are shown as the mean ± SEM with individual values. Statistical analyses were carried out using one-way ANOVA followed by Dunnett’s multiple comparisons test (*P < 0.05; **P < 0.01)
Fig. 3 Omega-3 PUFA treatment has an obvious effect on the α-diversity but not β-diversity of the gut microbiota in PCOS mice. The microbiota composition of control, PCOS and omega-3 mice was analyzed by 16 S rDNA pyrosequencing (n = 3 for each group). A Shannon curve. B Sob index. C Chao1 index. D Ace index. E UPGMA clustering method. F PCA of gut microbiota based on the OTU data of the control, PCOS, and omega-3 groups. PCA, principal component analysis; UPGMA, unweighted pair group method using arithmetic average. The data are shown as the mean ± SEM with individual values. Statistical analyses were carried out using one-way ANOVA followed by Dunnett’s multiple comparisons test (*P < 0.05; **P < 0.01)CC BY · PubMed Central
Fig. 4 Omega-3 PUFAs modulate the gut microbiota of PCOS mice. A Bacterial taxonomic profiling at the genus level of intestinal bacteria from different mouse groups. B-K Relative abundance of Lachnospiraceae_NK4A136_group, Oscillibacter, Alistipes, Eubacterium_xylanophilum_group, Alloprevotella, Intestinimonas, Akkermansia, Blautia, Lachnospiraceae_UCG-006, and Roseburia. L Heatmap of the 21 OTUs in the control group altered in PCOS in response to omega-3 PUFA treatment. The phylum, family, and genus names of the OTUs are shown in the right panel. The color of the spots in the left panel represents the relative abundance at the genus level in each group. The analyses were conducted using R software version 3.3.1
Fig. 4 Omega-3 PUFAs modulate the gut microbiota of PCOS mice. A Bacterial taxonomic profiling at the genus level of intestinal bacteria from different mouse groups. B-K Relative abundance of Lachnospiraceae_NK4A136_group, Oscillibacter, Alistipes, Eubacterium_xylanophilum_group, Alloprevotella, Intestinimonas, Akkermansia, Blautia, Lachnospiraceae_UCG-006, and Roseburia. L Heatmap of the 21 OTUs in the control group altered in PCOS in response to omega-3 PUFA treatment. The phylum, family, and genus names of the OTUs are shown in the right panel. The color of the spots in the left panel represents the relative abundance at the genus level in each group. The analyses were conducted using R software version 3.3.1CC BY · PubMed Central
Fig. 5 Gut microbiota mediates part of the beneficial effects of omega-3 PUFAs on the ovaries. Mice were randomly divided into four groups. PCOS mice were orally administered corn oil (PCOS) or omega-3 PUFAs (2 g/kg every 2 days). Horizontal fecal transfer from saline–treated PCOS mice is referred to as PCOS receivers (PCOS→PCOS). Horizontal fecal transfer from omega-3 PUFA-treated mice is referred to as omega-3 receivers (omega-3→PCOS). A Study design of the fecal transplantation experiment. B Body weight of the above four groups of mice. C Fasting blood glucose (n = 6). D-H Serum FSH, LH, LH/FSH ratio, E2 and T levels (n = 5). I Ovarian index (n = 4). J, K Representative estrous cycles. Error bars are expressed as the means ± SEMs. Statistical significance was determined by P values determined by two-tailed paired-samples t test (*P < 0.05). P, proestrus stage; E, estrus stage; M, metestrus stage; D, diestrus stage; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol 2; T, testosterone
Fig. 5 Gut microbiota mediates part of the beneficial effects of omega-3 PUFAs on the ovaries. Mice were randomly divided into four groups. PCOS mice were orally administered corn oil (PCOS) or omega-3 PUFAs (2 g/kg every 2 days). Horizontal fecal transfer from saline–treated PCOS mice is referred to as PCOS receivers (PCOS→PCOS). Horizontal fecal transfer from omega-3 PUFA-treated mice is referred to as omega-3 receivers (omega-3→PCOS). A Study design of the fecal transplantation experiment. B Body weight of the above four groups of mice. C Fasting blood glucose (n = 6). D-H Serum FSH, LH, LH/FSH ratio, E2 and T levels (n = 5). I Ovarian index (n = 4). J, K Representative estrous cycles. Error bars are expressed as the means ± SEMs. Statistical significance was determined by P values determined by two-tailed paired-samples t test (*P < 0.05). P, proestrus stage; E, estrus stage; M, metestrus stage; D, diestrus stage; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol 2; T, testosteroneCC BY · PubMed Central
Fig. 6 Omega-3 PUFAs improve the function and morphology of adipose tissues of PCOS in a gut microbiota–dependent manner. A Representative images of subcutaneous adipose tissues from control, PCOS, omega-3, and omega-3 + ABX mice. Scale bars: 50 μm. B-E Thermogenic markers in subcutaneous adipose tissues. F-I Thermogenic markers in brown adipose tissues. Error bars are expressed as the means ± SEMs. Statistical significance was determined by P values determined by one-way ANOVA followed by Dunnett’s multiple comparisons test (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001)
Fig. 6 Omega-3 PUFAs improve the function and morphology of adipose tissues of PCOS in a gut microbiota–dependent manner. A Representative images of subcutaneous adipose tissues from control, PCOS, omega-3, and omega-3 + ABX mice. Scale bars: 50 μm. B-E Thermogenic markers in subcutaneous adipose tissues. F-I Thermogenic markers in brown adipose tissues. Error bars are expressed as the means ± SEMs. Statistical significance was determined by P values determined by one-way ANOVA followed by Dunnett’s multiple comparisons test (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001)CC BY · PubMed Central
Fig. 7 Transferring feces from omega-3 PUFA-treated mice to PCOS mice changed the function and morphology of adipose tissues. A Representative images of subcutaneous adipose tissues from t-PCOS and t-Omega-3 mice. Scale bars: 50 μm. B-E Thermogenic markers in subcutaneous adipose tissues. F-I Thermogenic markers in brown adipose tissues. Error bars are expressed as the means ± SEMs. Statistical significance was determined by P values determined by two-tailed paired-samples t test (*P < 0.05)
Fig. 7 Transferring feces from omega-3 PUFA-treated mice to PCOS mice changed the function and morphology of adipose tissues. A Representative images of subcutaneous adipose tissues from t-PCOS and t-Omega-3 mice. Scale bars: 50 μm. B-E Thermogenic markers in subcutaneous adipose tissues. F-I Thermogenic markers in brown adipose tissues. Error bars are expressed as the means ± SEMs. Statistical significance was determined by P values determined by two-tailed paired-samples t test (*P < 0.05)CC BY · PubMed Central
Fig. 8 Omega-3 PUFAs ameliorate ovarian dysfunction associated with PCOS, likely involving direct effects on inhibiting ovarian inflammation. A-D The mRNA levels of IL-1β, TNF-α, IL-18 and CCL2 in the control, PCOS, omega-3 and omega-3 + ABX groups. E-H The mRNA levels of IL-1β, TNF-α, IL-18 and CCL2 in the t-PCOS and t-Omega-3 groups. Data are shown as the mean ± SEM. Statistical significance was determined by P values determined by one-way ANOVA followed by Dunnett’s multiple comparisons test and a two-tailed Mann–Whitney U test (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001)
Fig. 8 Omega-3 PUFAs ameliorate ovarian dysfunction associated with PCOS, likely involving direct effects on inhibiting ovarian inflammation. A-D The mRNA levels of IL-1β, TNF-α, IL-18 and CCL2 in the control, PCOS, omega-3 and omega-3 + ABX groups. E-H The mRNA levels of IL-1β, TNF-α, IL-18 and CCL2 in the t-PCOS and t-Omega-3 groups. Data are shown as the mean ± SEM. Statistical significance was determined by P values determined by one-way ANOVA followed by Dunnett’s multiple comparisons test and a two-tailed Mann–Whitney U test (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 69 · Cited by 27

Metadata

Authors
Zhang, H., Zheng, L., Li, C., Jing, J., Li, Z., Sun, S., Xue, T., Zhang, K., Xue, M., Cao, C., Ouyang, L., Qian, Z., Xu, R., He, Z., Ma, R., Chen, L., & Yao, B.
Affiliations
  • Nanjing General Hospital of Nanjing Military Command (CN)
  • Nanjing Normal University (CN)
  • Northern Jiangsu People's Hospital (CN)
  • Jiangsu University (CN)
Corresponding author
  • Ma, Rujun
  • Chen, Li
  • Yao, Bing
Venue
Journal of Ovarian Research
Published
2023-07-14
Volume
16
Issue
1
Pages
138-138
ISSN
1757-2215 (ISSN-L)
OpenAlex
W4384277040
Cited by
27
References
69
Citations by year
2026: 5 · 2025: 11 · 2024: 9 · 2023: 2
FWCI
6.47
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Ovarian Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (82271687, 82274651)
  • Jiangsu Provincial Key Research and Development Program (BE2022712)
  • Key Medical Research Projects of Jiangsu Provincial Health Commission (ZD2022004)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Keywords
polycystic ovary syndrome, omega-3 polyunsaturated fatty acids, gut microbiota, gut dysbiosis, insulin resistance, ovarian dysfunction, DHEA-induced PCOS, inflammation, oxidative stress, thermogenesis, brown adipose tissue, subcutaneous adipose tissue, female infertility, fecal microbiota transplantation, antibiotic therapy, UCP1, PGC-1α
MeSH terms
Gastrointestinal Microbiome, Animals, Dehydroepiandrosterone, Female, Insulin Resistance, Polycystic Ovary Syndrome, Fatty Acids, Omega-3, Dietary Supplements, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice. https://app.cochat.ai/papers/10.1186/s13048-023-01227-w
The paper
Zhang, H., Zheng, L., Li, C., Jing, J., Li, Z., Sun, S., Xue, T., Zhang, K., Xue, M., Cao, C., Ouyang, L., Qian, Z., Xu, R., He, Z., Ma, R., Chen, L., & Yao, B. (2023). Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice. Journal of Ovarian Research. https://doi.org/10.1186/s13048-023-01227-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.